Print Friendly, PDF & Email

A “Filaments” Perspective : 25 Years and Counting…

Clifford E Carnicom
Jan 13 2024

For the past several years, there has been some attention given to the presence of unusual filaments within blood samples, blood clots, and (purported) “vaccine” studies. If studied adequately, it will be determined that these filaments have a complex internal biology within them, down to the sub-micron level (minimum).  Various names and chemical identities have been assigned to these filaments, such as “ribbons”, “threads”, “graphene oxide”(i.e., elementary chemistry) and the like.  There are numerous implications from various researchers that these filaments originate from the advent of the “Covid Era”.

The characterization of these filaments as a product only of recent years, i.e., from purported “vaccines”, is mistaken.  Any characterization of the filaments as being of relatively simple or uniform chemistry is mistaken.  Any characterization of the filaments as being an unknown and mysterious entity (with no effort expended to remedy that ignorance) is equally inadequate and mistaken.

It is a disservice to simplify their nature, origin, constitution, and capabilities.  These filaments, actually a product of synthetic biology, have altered human biology in untold ways for decades and they are NOT a mystery as to their origin or general nature.  Any perpetuation of that myth is either from ignorance or with motive.

These unusual and remarkable filaments:

1. Have a known and documented existence of approximately 25 years.
2. Are of an extremely complex biological nature, internally down to the sub-micron level (at a minimum).
3. Have been intensively studied by Carnicom Institute (CI) and others for this same time period.
4. Are directly a physical aspect of the health condition known as “Morgellons”.
5. Have been shown to have a direct role in blood clotting and blood changes that appear to occur more frequently and visibly within the Covid Era.
6. Are ultimately of a synthetic, engineered, xenobiotic nature.
7. Were first identified to originate from an environmental source (geoengineering, bioengineering research).
8. Were given to the United States Environmental Protection Agency (EPA) in the year 2000 with a request for identification on behalf of the public welfare; this request was refused via a “policy” decision.
9. Are a direct metabolic development of the Cross Domain Bacteria (CDB) under study at CI over these same decades.
10. Have some variation in form (a degree of pleomorphism) and size (although all are primarily microscopic) and all have an existence that can be shown to directly originate from the CDB.
11. Are the subject of a false certified paid commercial laboratory report (organic) conducted in Jan 2000.
12. Are the subject of a truthful certified commercial laboratory report (inorganic) conducted prior to 2017.
13. Can be shown to be a source of synthetic blood production under appropriate culture conditions.
14. The filaments can be demonstrated to be distributed throughout human biology, not just blood.
15. Can be cultured successfully from these same CDB.

These conclusions are justified with the research available at CI beginning in 1999 and they carry forward to the present day.

As the available research is too lengthy to present, a sampling of representative images and titles from the ~450 paper research set will be given to give a sense of the state of affairs:


Jul 05 2001


May 11 2000


Nov 04 1999


Aug 26, 1999


Dec 14 2009


Dec 10 2007


Cross-Domain Bacteria Isolation
May 17 2014


CDB: Growth Progressions
Jun 13 2014


The New Biology
Jan 18 2014


Morgellons : An International Presence
Aug 10 2016


Global Validation
Nov 26 2017


Bean Growth Report
Oct 03 2017


Morgellons : Unique Protein Isolated & Characterized
Oct 01 2017


Blood Alterations : A Six Part Series
Aug 2022 – Oct 2022